GLJ Research — sell-side record
GLJ Research made 36 rating actions across 8 covered names in the last 12 months, 25% of them Buy-type and 72% Sell-type. Of its 23 price targets that resolved, 9 (39%) were reached while they stood, 11 were replaced by GLJ Research before their deadline and 3 fell short at it. 3 of its 5 Buy- and Sell-type ratings that ran a full horizon agreed with how the stock did against its sector.
8 covered names with a call from GLJ Research in the last two years, checked through 2026-10-29. Rebuilt every morning.
What its Holds say: GLJ Research's 1 Hold-type ratings in the last 12 months carried a median price target +5% from the price on the day; 0% sat below the price.
By name
| Ticker | Rating actions, 12 mo | Targets reached | Replaced early | Short | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|
| ENPH | 5 | 1 (14%) | 6 | 0 | 7 | 1 of 1 |
| FSLR | 4 | 3 (75%) | 1 | 0 | 4 | — |
| GEV | 2 | 1 (33%) | 2 | 0 | 3 | 1 of 1 |
| SEDG | 2 | 0 (0%) | 0 | 3 | 3 | 0 of 1 |
| RUN | 7 | 1 (50%) | 1 | 0 | 2 | — |
| NXT | 4 | 2 (100%) | 0 | 0 | 2 | — |
| CCJ | 1 | 1 (50%) | 1 | 0 | 2 | 1 of 1 |
| TSLA | 11 | — | — | — | 0 | 0 of 1 |
Per-name counts are small; no percentage on one name is a measure of skill.
Latest calls
| Date | Ticker | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-28 | ENPH | Sell | reiterated | $24.99 | $21 | running to 2027-10-28 | -19.1% |
| 2026-10-26 | ENPH | Sell | maintained | $30.36 | $21 | running to 2027-10-26 | -6.3% |
| 2026-10-22 | TSLA | Sell | reiterated | $374.58 | $25 | — | -1.1% |
| 2026-10-15 | TSLA | Sell | reiterated | $362.44 | $25 | — | +1.6% |
| 2026-09-22 | FSLR | Buy | maintained | $200.78 | $250 | running to 2027-09-22 | -6.3% |
| 2026-09-14 | GEV | Sell | initiated | $874.76 | $470 | running to 2027-09-14 | -17.7% |
| 2026-09-04 | TSLA | Sell | reiterated | $354.08 | $25 | — | +10.1% |
| 2026-08-18 | TSLA | Sell | reiterated | $336.87 | $25 | — | -11.6% |
| 2026-08-17 | RUN | Sell | reiterated | $9.83 | $5 | running to 2027-08-17 | -17.1% |
| 2026-08-05 | NXT | Buy | reiterated | $99.81 | $149 | running to 2027-08-05 | -13.2% |
Other firms: Barclays · Wells Fargo · Morgan Stanley · UBS · Citigroup · RBC Capital · JPMorgan · Truist Securities · TD Cowen · Cantor Fitzgerald · Evercore ISI Group · Piper Sandler. All firms.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.